Northern Trust
PRAX icon

Northern Trust’s Praxis Precision Medicines PRAX Stock Holding History

Northern Trust’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.6M Buy
240,887
+12,953
+6% +$4.1M 0.01% 922
2026
Q1 		$73.4M Buy
227,934
+35,650
+19% +$11M 0.01% 895
2025
Q4 		$56.7M Buy
192,284
+23,931
+14% +$4.46M 0.01% 1033
2025
Q3 		$8.92M Sell
168,353
-45,359
-21% -$2.2M ﹤0.01% 2180
2025
Q2 		$8.99M Buy
213,712
+48,529
+29% +$1.85M ﹤0.01% 2138
2025
Q1 		$6.26M Sell
165,183
-2,407
-1% -$150K ﹤0.01% 2302
2024
Q4 		$12.9M Buy
167,590
+15,323
+10% +$1.11M ﹤0.01% 1976
2024
Q3 		$8.76M Buy
152,267
+104,198
+217% +$5.63M ﹤0.01% 2145
2024
Q2 		$1.99M Buy
48,069
+20,790
+76% +$983K ﹤0.01% 2900
2024
Q1 		$1.66M Buy
27,279
+7,915
+41% +$355K ﹤0.01% 3056
2023
Q4 		$431K Sell
19,364
-370
-2% -$6.66K ﹤0.01% 3588
2023
Q3 		$506K Buy
19,734
+11,701
+146% +$221K ﹤0.01% 3517
2023
Q2 		$139K Sell
8,033
-19,047
-70% -$292K ﹤0.01% 3952
2023
Q1 		$329K Buy
27,080
+3,622
+15% +$153K ﹤0.01% 3626
2022
Q4 		$837K Sell
23,458
-1,248
-5% -$38.9K ﹤0.01% 3326
2022
Q3 		$841K Sell
24,706
-58
-0.2% -$2.89K ﹤0.01% 3354
2022
Q2 		$911K Buy
24,764
+3,590
+17% +$383K ﹤0.01% 3365
2022
Q1 		$3.24M Buy
21,174
+219
+1% +$45K ﹤0.01% 2841
2021
Q4 		$6.19M Buy
20,955
+1,073
+5% +$315K ﹤0.01% 2558
2021
Q3 		$5.51M Buy
19,882
+5,003
+34% +$1.36M ﹤0.01% 2663
2021
Q2 		$4.08M Buy
14,879
+6,833
+85% +$2.45M ﹤0.01% 2969
2021
Q1 		$3.95M Sell
8,046
-442
-5% -$314K ﹤0.01% 2888
2020
Q4 		$7.01M Buy
+8,488
New +$4.95M ﹤0.01% 2478

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Northern Trust's PRAX Position: Q2 2026 in Review

Northern Trust increased its Praxis Precision Medicines (PRAX) stake by 5.7% in Q2 2026, buying an estimated $4.1M and bringing the position to 240,887 shares worth $80.6M. The position accounts for 0.01% of the portfolio, ranked #922.

Northern Trust first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Northern Trust held 240,887 shares of Praxis Precision Medicines worth $80.6M as of Q2 2026.
  • Northern Trust bought 12,953 Praxis Precision Medicines shares in Q2 2026, an estimated $4.1M.
  • Praxis Precision Medicines made up 0.01% of Northern Trust's portfolio in Q2 2026, its #922 holding.
  • Northern Trust first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.